On the mechanism of the synergistic effect of perazine and hexobarbital.
D000109:Acetylcholine / Q000378:metabolism; D000758:Anesthesia; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001711:Biotransformation; D001712:Biperiden / Q000494:pharmacology; D001921:Brain / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D004878:Ergotamine / Q000494:pharmacology; D005260:Female; D006591:Hexobarbital / Q000378:metabolism / Q000494:pharmacology*; D006801:Humans; D010640:Phenothiazines; D010646:Phentolamine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism
D014150:Antipsychotic Agents; D010640:Phenothiazines; D010879:Piperazines; D001712:Biperiden; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D006591:Hexobarbital; D000109:Acetylcholine; D004878:Ergotamine; D004298:Dopamine; D010646:Phentolamine